نتائج البحث

Real-world effectiveness of brentuximab vedotin versus physicians' choice chemotherapy in patients with relapsed/refractory Hodgkin lymphoma following autologous stem cell transplantation in the United Kingdom and Germany.

• Authors : Zagadailov EA; a Millennium Pharmaceuticals, Inc., a wholly owned subsidiary of Takeda Pharmaceutical Company Limited , Cambridge , MA , USA.; Corman S

Subjects: Antineoplastic Combined Chemotherapy Protocols/Antineoplastic Combined Chemotherapy Protocols/Antineoplastic Combined Chemotherapy Protocols/*therapeutic use ; Hodgkin Disease/Hodgkin Disease/Hodgkin Disease/*pathology ; Hodgkin Disease/Hodgkin Disease/Hodgkin Disease/*therapy

• Source: Leukemia & lymphoma [Leuk Lymphoma] 2018 Jun; Vol. 59 (6), pp. 1413-1419. Date of Electronic Publication: 2017 Oct 18.Publisher: Taylor & Francis Country of Publication: United States NLM ID: 9007422 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

تفاصيل العنوان

Brentuximab vedotin in patients with relapsed or refractory Hodgkin lymphoma who are Ineligible for autologous stem cell transplant: A Germany and United Kingdom retrospective study.

• Authors : Bröckelmann PJ; Department I of Internal Medicine and German Hodgkin Study Group (GHSG), University Hospital of Cologne, Cologne, Germany.; Zagadailov EA

Subjects: Antineoplastic Agents/Antineoplastic Agents/Antineoplastic Agents/*therapeutic use ; Hodgkin Disease/Hodgkin Disease/Hodgkin Disease/*pathology ; Hodgkin Disease/Hodgkin Disease/Hodgkin Disease/*therapy

• Source: European journal of haematology [Eur J Haematol] 2017 Dec; Vol. 99 (6), pp. 553-558. Date of Electronic Publication: 2017 Oct 16.Publisher: Blackwell Country of Publication: England NLM ID: 8703985 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1600-0609

تفاصيل العنوان

Management of Hodgkin lymphoma in the era of brentuximab vedotin: real-world data from five European countries.

• Authors : Collins GP; a Oxford Cancer and Haematology Centre , Churchill Hospital , Oxford , UK.; Rueda A

Subjects: Hodgkin Disease/Hodgkin Disease/Hodgkin Disease/*therapy ; Immunoconjugates/Immunoconjugates/Immunoconjugates/*therapeutic use ; Stem Cell Transplantation/Stem Cell Transplantation/Stem Cell Transplantation/*methods

• Source: Leukemia & lymphoma [Leuk Lymphoma] 2018 Sep; Vol. 59 (9), pp. 2113-2120. Date of Electronic Publication: 2018 Jan 16.Publisher: Taylor & Francis Country of Publication: United States NLM ID: 9007422 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

تفاصيل العنوان

Health utilities in relation to treatment response and adverse events in relapsed/refractory Hodgkin lymphoma and systemic anaplastic large cell lymphoma.

• Authors : Swinburn P; ICON, Patient Reported Outcomes , Oxford , UK.; Shingler S

Subjects: Health Services/Health Services/Health Services/*statistics & numerical data ; Health Surveys/Health Surveys/Health Surveys/*statistics & numerical data ; Hodgkin Disease/Hodgkin Disease/Hodgkin Disease/*therapy

• Source: Leukemia & lymphoma [Leuk Lymphoma] 2015 Jun; Vol. 56 (6), pp. 1839-45. Date of Electronic Publication: 2014 Nov 03.Publisher: Taylor & Francis Country of Publication: United States NLM ID: 9007422 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

تفاصيل العنوان

Correlation study of malignant lymphoma and breast Cancer in different gender European populations: mendelian randomization analysis.

• Authors : Chen, Xiong¹ (AUTHOR); Hu, GuoHuang¹ (AUTHOR)

• Source: BMC Genomic Data. 10/9/2023, Vol. 24 Issue 1, p1-7. 7p.

تفاصيل العنوان

11. Cancers attributable to infection in the UK in 2010.

• Authors : Parkin DM; Centre for Cancer Prevention, Wolfson Institute of Preventive Medicine, Queen Mary University of London, Charterhouse Square, London, UK.

Subjects: Helicobacter Infections/Helicobacter Infections/Helicobacter Infections/*complications ; Infections/Infections/Infections/*complications ; Neoplasms/Neoplasms/Neoplasms/*etiology

• Source: British journal of cancer [Br J Cancer] 2011 Dec 06; Vol. 105 Suppl 2, pp. S49-56.Publisher: Nature Publishing Group on behalf of Cancer Research UK Country of Publication: England NLM ID: 0370635 Publication Model: Print Cited Medium:

تفاصيل العنوان

Long-term outcome for immune suppression and immune related lymphoproliferative disorder: prospective data from the United Kingdom Children's Leukaemia and Cancer Group registry 1994-2004.

• Authors : Taj, Mary M.¹ (AUTHOR) ; Hadzic, Nedim² (AUTHOR); Height, Susan E.² (AUTHOR)

• Source: Leukemia & Lymphoma. May2012, Vol. 53 Issue 5, p842-848. 7p. 3 Charts, 6 Graphs.

تفاصيل العنوان

Serum lipid trajectories in the years before a lymphoma diagnosis.

• Authors : Fortuny, Joan¹ (AUTHOR); Plana, Estel¹ (AUTHOR); Kaye, James A.² (AUTHOR)

• Source: Leukemia & Lymphoma. Feb 2022, Vol. 63 Issue 2, p291-303. 13p.

تفاصيل العنوان

Molecular variants of the ATM gene in Hodgkin's disease in children.

• Authors : Liberzon, E.¹; Avigad, S.^1,2 ; Yaniv, I.^1,2

• Source: British Journal of Cancer. 1/26/2004, Vol. 90 Issue 2, p522-525. 4p.

تفاصيل العنوان